{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:35:50Z","timestamp":1755218150494,"version":"3.43.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02997-3","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T04:21:00Z","timestamp":1754454060000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a PPP1R14B-associated immune prognostic model for hepatocellular carcinoma"],"prefix":"10.1186","volume":"30","author":[{"given":"Ligang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiushi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yigang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Facai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengqing","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"3","key":"2997_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2997_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1): 6. https:\/\/doi.org\/10.1038\/s41572-020-00240-3.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2997_CR3","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.gendis.2020.01.014","volume":"7","author":"W Wang","year":"2020","unstructured":"Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis. 2020;7(3):308\u201319. https:\/\/doi.org\/10.1016\/j.gendis.2020.01.014.","journal-title":"Genes Dis"},{"issue":"1","key":"2997_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s1470-2045(21)00604-5","volume":"23","author":"T Yau","year":"2022","unstructured":"Yau T, Park JW, Finn RS, et al. Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol. 2022;23(1):77\u201390. https:\/\/doi.org\/10.1016\/s1470-2045(21)00604-5.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2997_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358\u201380. https:\/\/doi.org\/10.1002\/hep.29086.","journal-title":"Hepatology"},{"issue":"4","key":"2997_CR6","doi-asserted-by":"publisher","first-page":"452","DOI":"10.21037\/hbsn-20-480","volume":"9","author":"DY Xie","year":"2020","unstructured":"Xie DY, Ren ZG, Zhou J, Fan J, Gao Q. 2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights. Hepatobiliary Surg Nutr. 2020;9(4):452\u201363. https:\/\/doi.org\/10.21037\/hbsn-20-480.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"6","key":"2997_CR7","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1002\/hep.32447","volume":"75","author":"F Foerster","year":"2022","unstructured":"Foerster F, Gairing SJ, Ilyas SI, Galle PR. Emerging immunotherapy for HCC: a guide for hepatologists. Hepatology. 2022;75(6):1604\u201326. https:\/\/doi.org\/10.1002\/hep.32447.","journal-title":"Hepatology"},{"issue":"1","key":"2997_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12967-020-02255-6","volume":"18","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhu J, Liu Y, et al. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma. J Transl Med. 2020;18(1):67. https:\/\/doi.org\/10.1186\/s12967-020-02255-6.","journal-title":"J Transl Med"},{"issue":"1","key":"2997_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12967-020-02691-4","volume":"19","author":"X Gu","year":"2021","unstructured":"Gu X, Guan J, Xu J, et al. Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes. J Transl Med. 2021;19(1):26. https:\/\/doi.org\/10.1186\/s12967-020-02691-4.","journal-title":"J Transl Med"},{"issue":"3","key":"2997_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.cell.2009.10.006","volume":"139","author":"Y Shi","year":"2009","unstructured":"Shi Y. Serine\/threonine phosphatases: mechanism through structure. Cell. 2009;139(3):468\u201384. https:\/\/doi.org\/10.1016\/j.cell.2009.10.006.","journal-title":"Cell"},{"key":"2997_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188433","author":"J Felgueiras","year":"2020","unstructured":"Felgueiras J, Jer\u00f3nimo C, Fardilha M. Protein phosphatase 1 in tumorigenesis: is it worth a closer look? Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2020. https:\/\/doi.org\/10.1016\/j.bbcan.2020.188433.","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"2997_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.763561","volume":"12","author":"M Deng","year":"2021","unstructured":"Deng M, Peng L, Li J, et al. PPP1R14B is a prognostic and immunological biomarker in pan-cancer. Front Genet. 2021;12: 763561. https:\/\/doi.org\/10.3389\/fgene.2021.763561.","journal-title":"Front Genet"},{"issue":"1","key":"2997_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41467-017-02272-y","volume":"9","author":"M Chen","year":"2018","unstructured":"Chen M, Wan L, Zhang J, et al. Deregulated PP1\u03b1 phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism. Nat Commun. 2018;9(1):159. https:\/\/doi.org\/10.1038\/s41467-017-02272-y.","journal-title":"Nat Commun"},{"issue":"2","key":"2997_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbrc.2019.12.064","volume":"523","author":"Z Jin","year":"2020","unstructured":"Jin Z, Zhao X, Cui L, et al. UBE2c promotes the progression of head and neck squamous cell carcinoma. Biochem Biophys Res Commun. 2020;523(2):389\u201397. https:\/\/doi.org\/10.1016\/j.bbrc.2019.12.064.","journal-title":"Biochem Biophys Res Commun"},{"key":"2997_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2022.101845","volume":"77","author":"N Xiang","year":"2022","unstructured":"Xiang N, Chen T, Zhao X, Zhao M. In vitro assessment of roles of PPP1R14B in cervical and endometrial cancer. Tissue Cell. 2022;77: 101845. https:\/\/doi.org\/10.1016\/j.tice.2022.101845.","journal-title":"Tissue Cell"},{"key":"2997_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cells9030561","author":"AMK Law","year":"2020","unstructured":"Law AMK, Valdes-Mora F, Gallego-Ortega D. Myeloid-derived suppressor cells as a therapeutic target for cancer. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9030561.","journal-title":"Cells"},{"issue":"1","key":"2997_CR17","doi-asserted-by":"publisher","DOI":"10.4161\/21624011.2014.954829","volume":"4","author":"O Draghiciu","year":"2015","unstructured":"Draghiciu O, Lubbers J, Nijman HW, Daemen T. Myeloid derived suppressor cells-an overview of combat strategies to increase immunotherapy efficacy. Oncoimmunology. 2015;4(1): e954829. https:\/\/doi.org\/10.4161\/21624011.2014.954829.","journal-title":"Oncoimmunology"},{"issue":"10","key":"2997_CR18","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"issue":"D1","key":"2997_CR19","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2012","unstructured":"Yang W, Soares J, Greninger P, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2012;41(D1):D955\u201361. https:\/\/doi.org\/10.1093\/nar\/gks1111.","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"2997_CR20","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1158\/0008-5472.CAN-21-2934","volume":"82","author":"EHK Mok","year":"2022","unstructured":"Mok EHK, Leung CON, Zhou L, et al. Caspase-3-induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma. Cancer Res. 2022;82(17):3102\u201315. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-2934.","journal-title":"Cancer Res"},{"key":"2997_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.177457","volume":"998","author":"M Shao","year":"2025","unstructured":"Shao M, Zhao T, Qian L, et al. Erythromycin repurposing for hepatocellular carcinoma treatment: targeting CD24 to enhance anti-tumor immunity. Eur J Pharmacol. 2025;998: 177457. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177457.","journal-title":"Eur J Pharmacol"},{"key":"2997_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000301","author":"DJ Park","year":"2020","unstructured":"Park DJ, Sung PS, Kim JH, et al. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1. J Immunother Cancer. 2020. https:\/\/doi.org\/10.1136\/jitc-2019-000301.","journal-title":"J Immunother Cancer"},{"issue":"13","key":"2997_CR23","doi-asserted-by":"publisher","first-page":"6995","DOI":"10.3390\/ijms22136995","volume":"22","author":"AJ Boutilier","year":"2021","unstructured":"Boutilier AJ, Elsawa SF. Macrophage polarization states in the tumor microenvironment. Int J Mol Sci. 2021;22(13):6995. https:\/\/doi.org\/10.3390\/ijms22136995.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2997_CR24","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1002\/ptr.7058","volume":"35","author":"AM Saeedifar","year":"2021","unstructured":"Saeedifar AM, Mosayebi G, Ghazavi A, Bushehri RH, Ganji A. Macrophage polarization by phytotherapy in the tumor microenvironment. Phytother Res. 2021;35(7):3632\u201348. https:\/\/doi.org\/10.1002\/ptr.7058.","journal-title":"Phytother Res"},{"issue":"10","key":"2997_CR25","doi-asserted-by":"publisher","DOI":"10.4161\/onci.26066","volume":"2","author":"C Gu-Trantien","year":"2013","unstructured":"Gu-Trantien C, Willard-Gallo K. Tumor-infiltrating follicular helper T cells: the new kids on the block. Oncoimmunology. 2013;2(10): e26066. https:\/\/doi.org\/10.4161\/onci.26066.","journal-title":"Oncoimmunology"},{"issue":"1","key":"2997_CR26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W Tang","year":"2020","unstructured":"Tang W, Chen Z, Zhang W, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5(1):87. https:\/\/doi.org\/10.1038\/s41392-020-0187-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"2997_CR27","doi-asserted-by":"publisher","first-page":"953","DOI":"10.4240\/wjgs.v13.i9.953","volume":"13","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Liu Y, Zhou L, Du GS, He Q. Trends of rapamycin in survival benefits of liver transplantation for hepatocellular carcinoma. World J Gastrointest Surg. 2021;13(9):953\u201366. https:\/\/doi.org\/10.4240\/wjgs.v13.i9.953.","journal-title":"World J Gastrointest Surg"},{"issue":"5","key":"2997_CR28","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3390\/ijms19051294","volume":"19","author":"L Caja","year":"2018","unstructured":"Caja L, Dituri F, Mancarella S, et al. TGF-\u03b2 and the tissue microenvironment: relevance in fibrosis and cancer. Int J Mol Sci. 2018;19(5):1294. https:\/\/doi.org\/10.3390\/ijms19051294.","journal-title":"Int J Mol Sci"},{"key":"2997_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.654684","volume":"11","author":"S Liu","year":"2021","unstructured":"Liu S, Liang J, Liu Z, et al. The role of CD276 in cancers. Front Oncol. 2021;11: 654684. https:\/\/doi.org\/10.3389\/fonc.2021.654684.","journal-title":"Front Oncol"},{"key":"2997_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.701006","volume":"12","author":"WT Zhou","year":"2021","unstructured":"Zhou WT, Jin WL. B7\u2013H3\/CD276: an emerging cancer immunotherapy. Front Immunol. 2021;12: 701006. https:\/\/doi.org\/10.3389\/fimmu.2021.701006.","journal-title":"Front Immunol"},{"key":"2997_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032652","author":"LY Tian","year":"2023","unstructured":"Tian LY, Smit DJ, Jucker M. The role of PI3K\/AKT\/mTOR signaling in hepatocellular carcinoma metabolism. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms24032652.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2997_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/biom15030344","volume":"15","author":"M Eto","year":"2025","unstructured":"Eto M. Rediscovery of PHI-1\/PPP1R14B: emerging roles of cellular PP1 signaling mediated by the PPP1R14B gene product in multiple cancers and beyond. Biomolecules. 2025;15(3): 344. https:\/\/doi.org\/10.3390\/biom15030344.","journal-title":"Biomolecules"},{"issue":"3","key":"2997_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1158\/0008-5472.CAN-22-2709","volume":"83","author":"L Liao","year":"2023","unstructured":"Liao L, Zhang YL, Deng L, et al. Protein phosphatase 1 subunit PPP1R14B stabilizes STMN1 to promote progression and paclitaxel resistance in triple-negative breast cancer. Cancer Res. 2023;83(3):471\u201384. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-2709.","journal-title":"Cancer Res"},{"issue":"8","key":"2997_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119840","volume":"1871","author":"N Zhou","year":"2024","unstructured":"Zhou N, Guo C, Du J, et al. PPP1R14B-mediated phosphorylation enhances protein stability of RPS6KA1 to promote hepatocellular carcinoma tumorigenesis. Biochim Biophys Acta Mol Cell Res. 2024;1871(8): 119840. https:\/\/doi.org\/10.1016\/j.bbamcr.2024.119840.","journal-title":"Biochim Biophys Acta Mol Cell Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02997-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02997-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02997-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T04:21:01Z","timestamp":1754454061000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02997-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2997"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02997-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"type":"electronic","value":"2047-783X"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal-based experimental procedures executed in this investigation were examined and authorized by the Animal Ethics Committee at Zhongda Hospital, Southeast University (Approval number: 2021ZDSYLL012-P01), following established protocols for laboratory animal welfare and utilization. No human subjects or patient data were involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"719"}}